Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 1467 entries
View as:

Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria

Phase: N/A Priority: Normal
NCT ID: NCT01445938 Org: User:
Start: 10/31/11 End: 01/31/12 Due: 01/31/13

A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02514668 Org: User:
Start: 09/01/15 End: 12/02/21 Due: 12/02/22

A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))

Phase: N/A Priority: Normal
NCT ID: NCT05731128 Org: User:
Start: 01/12/23 End: 03/24/27 Due: 03/24/28

Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis

Phase: N/A Priority: Normal
NCT ID: NCT00556179 Org: User:
Start: 09/30/07 End: - Due: -

Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT06258057 Org: User:
Start: 01/16/24 End: 12/31/25 Due: 12/31/26

Docetaxel in Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00261703 Org: User:
Start: 12/31/02 End: 07/31/10 Due: 07/31/11

12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00046150 Org: User:
Start: 05/31/02 End: 12/31/02 Due: 12/31/03

Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT02715726 Org: User:
Start: 07/27/16 End: 08/06/18 Due: 08/06/19

Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)

Phase: N/A Priority: Normal
NCT ID: NCT00077844 Org: User:
Start: 01/31/04 End: 09/30/05 Due: 09/30/06

Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

Phase: N/A Priority: Normal
NCT ID: NCT05468320 Org: User:
Start: 11/21/22 End: 12/26/24 Due: 12/26/25

Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00273546 Org: User:
Start: 05/31/99 End: 02/28/06 Due: 02/28/07

Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT06824194 Org: User:
Start: 02/18/25 End: 05/12/27 Due: 05/12/28

An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00239967 Org: User:
Start: 05/31/05 End: 02/28/07 Due: 02/28/08

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05769777 Org: User:
Start: 04/03/23 End: 10/09/28 Due: 10/09/29

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Phase: N/A Priority: Normal
NCT ID: NCT00539981 Org: User:
Start: 09/15/07 End: 05/28/08 Due: 05/28/09

Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

Phase: N/A Priority: Normal
NCT ID: NCT02898454 Org: User:
Start: 11/28/16 End: 11/16/18 Due: 11/16/19

Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®

Phase: N/A Priority: Normal
NCT ID: NCT00319553 Org: User:
Start: 05/31/06 End: 12/31/08 Due: 12/31/09

GILT Docetaxel - Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00174629 Org: User:
Start: 06/30/01 End: - Due: -

Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Asia

Phase: N/A Priority: Normal
NCT ID: NCT01218906 Org: User:
Start: 08/31/10 End: 03/31/12 Due: 03/31/13

IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment)

Phase: N/A Priority: Normal
NCT ID: NCT00268632 Org: User:
Start: 08/31/99 End: - Due: -

Comparative Study of a Smartphone-Linked Self-Monitoring System Versus a Traditional One for Improving Metabolic Control and Compliance to Self-Monitoring of Blood Glucose

Phase: N/A Priority: Normal
NCT ID: NCT02073188 Org: User:
Start: 06/30/12 End: 09/30/14 Due: 09/30/15

An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT01764997 Org: User:
Start: 04/30/13 End: 01/31/15 Due: 01/31/16

TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN

Phase: N/A Priority: Normal
NCT ID: NCT00539630 Org: User:
Start: 11/30/02 End: - Due: -

Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT00478972 Org: User:
Start: 04/30/07 End: 01/31/09 Due: 01/31/10

Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01324583 Org: User:
Start: 01/31/11 End: 11/30/14 Due: 11/30/15